Hormone Therapy Overview for the Behavioral Health Provider. Julie Thompson, PA Fenway Health
|
|
- Edwina O’Neal’
- 6 years ago
- Views:
Transcription
1 Hormone Therapy Overview for the Behavioral Health Provider Julie Thompson, PA Fenway Health
2 Continuing Medical Education Disclosure Program Faculty: Julie Thompson, PA Current Position: Physician s Assistant, Fenway Health Disclosures: No relevant financial relationships. All hormone therapy for transgender people is off-label. It is the policy of The National LGBT Health Education Center, Fenway Health that all CME planning committee/faculty/authors/editors/staff disclose relationships with commercial entities upon nomination/invitation of participation. Disclosure documents are reviewed for potential conflicts of interest and, if identified, they are resolved prior to confirmation of participation. Only participants who have no conflict of interest or who agree to an identified resolution process prior to their participation were involved in this CME activity.
3 Hormone Readiness
4 WPATH Criteria for Initiating Hormone Therapy Persistent, well-documented gender dysphoria Capacity to make a fully informed decision and consent to treatment Age of majority in a given country If significant medical or mental health concerns are present, they must be reasonably well-controlled
5 Informed Consent Model Effectively communicate benefits, risks and alternatives of treatment to patient Judge that the patient is able to understand and consent to the treatment Informed consent model does not preclude mental health care Based on clinical judgment Lack of contraindications Pt. capacity to give informed consent Pt with clear understanding of information they are consenting to expectations, knowns, unknowns
6 Initial Visits Reviewing implications and obtaining consent: Reproductive Rights - freezing sperm/eggs, ability to get pregnant despite testosterone therapy Permanent vs transient changes Goals of short-term and long-term Short and long-term risks, screenings unknowns! Social implications supports job/career sex
7 Hormone Therapy
8 FTM Hormone Therapy
9 Female to Male Treatment Options Injectable Testosterone Testosterone Enanthate or Cypionate Transdermal Testosterone Androderm Topical testosterone Gels in packets and pumps, multiple formulations (Testim, Androgel) Axiron 2% pump gel for axillary application 1 pump to each axilla daily Testosterone Pellet Testopel- implant q 3 to 6 months
10 Female to Male Treatment Options
11 Masculinizing Effects of Testosterone Effect Onset (months) Maximum (years) Skin oiliness/acne Fat redistribution Cessation of Menses 2-6 Clitoral enlargement Vaginal atrophy Emotional changes Increased sex drive
12 Masculinizing Effects of Testosterone Effect Onset (months) Maximum (years) Deepening of voice Facial/Body Hair Growth Scalp Hair Loss 6-12 Increased Muscle Mass & Strength Coarser Skin/ Increased Sweating Weight Gain/Fluid Retention Mild Breast Atrophy Weakening of Tendons
13 Other Treatment Therapies for FTM Testosterone cream in Aquaphor for clitoral enlargement Estrogen vaginal cream for atrophy Rogaine or Finasteride for male pattern baldness Use of Progesterone aid in cessation of menses before or after starting testosterone therapy LARC for cessation of menses/birth control
14 MTF Hormone Therapy
15 Male to Female Treatment Options Antiandrogens Spironolactone (aldactone) Finasteride (Proscar) Oral Estrogens Estradiol (estrace) Premarin (conjugated estrogens) Transdermal Estrogens Estradiol patch, twice weekly Injectable Estrogens Estradiol valerate 5-20mg IM q2 weeks Estradiol cypionate 2-10mg IM weekly
16 Feminizing Effects of Estrogens and Anti-Androgens Effect Onset (months) Maximum (months) Decreased Libido Decreased Spontaneous Erections Breast Growth Decreased Testicular Volume Decreased Sperm Production Unknown Unknown Redistribution of Body Fat Decrease in Muscle Mass Softening of Skin 3-6 Unknown Decreased Terminal Hair 6-12 >36
17 Cosmetic Therapies Hydroquinone Topical treatment for pigmentation caused by estrogen therapy Hair Removal Eflornithine (Vaniqa) cream Electrolysis Laser hair removal
18 Physical Implications and Risks
19 Risks of Estrogen Therapy Venous thrombosis/thromboembolism Weight gain Decreased libido Increased triglycerides Elevated blood pressure Decreased glucose tolerance /risk of diabetes Gallbladder disease Benign pituitary prolactinoma Breast cancer(?) Infertility
20 Health Considerations for the Trans Feminine Spectrum Thrombosis/Blood clots Rates of 1 to 6% reported Associated with cigarette smoking and immobility (surgery) Type of anti-androgen and estrogen used (ethinyl estradiol)
21 Health Considerations for the Trans Feminine Spectrum Cardiovascular disease About 50 to 60% higher risk in transwomen Associated with smoking and higher baseline cholesterol levels Higher rates of diabetes may play a role Type of estrogen used
22 Risks of Testosterone Therapy Lower HDL Elevated triglycerides Increased homocysteine levels Hepatotoxicity? Polycythemia Unknown effects on breast, endometrial, ovarian tissues Increased risk of sleep apnea (Insulin resistance) Infertility
23 Health Considerations for Trans Masculine Spectrum Polycythemia/ increase in red blood cells?risk of blood clots, heart attacks and strokes Dosage and form of testosterone used
24 Good News No increase in the incidence of cancers in transwomen or transmen.
25 Risks of Hormone Therapy 2011 review of Dutch patient cohort 966 transwomen and 365 transmen 50% higher mortality rate in MTF patients compared to general population Most of the increase in mortality was due to higher rates of suicide, drug-related deaths, and AIDS The mortality rate for trans men was similar to the general population
26 Mental Health Implications
27 Mental Health Issues Estrogens can potentially worsen depression Testosterone may destabilize bipolar disorder, schizophrenia, impulse control disorders
28 Mental Health Benefit Access to cross-sex hormone therapy has been reported in a number of studies to be associated with better functioning in terms of : gender dysphoria relief quality of life improvement psychological functioning decrease in suicide attempts improve body image
29 Depression and Suicide Weighing risks and benefits: Well-controlled BH issues vs Harm Reduction and Baseline functioning Suicide rates: In some surveys, up to 40% of transgender/gender variant individuals report having ATTEMPTED suicide. Suicidal ideation rates as high as 64% A 2009 NYC Metro survey of 571 transwomen found a lifetime history of suicidal thinking of approximately 53%, suicidal planning of approximately 35%, and attempted suicide rate of 28 35%
30 Depression and Suicide A 2009 study of 515 transgender individuals in San Francisco found that depression approaches 62% in trans women and 55% in trans men NYC metropolitan area survey found that 52 54% of trans women have a lifetime history of major depression
31 Depression and Suicide ** But, suicide rates remain higher than in the general population even after hormones or surgery. Minority Stress Discrimination Expectations not met
32 Additional Topics in Hormone Therapy
33 Options for Non-binary Identified People Lower doses? Shorter courses? Testosterone blockers alone? What are the risks of stopping hormone therapy?
34 Questions?
35 Resources UCSF Center of Excellence for Transgender Health Guidelines Vancouver Coastal Health Guidelines The Endocrine Society Guidelines (First published September, 2009) Transsexual-Persons.pdf Transline Surgical options:
HEALTH CARE FOR TRANSGENDER PERSONS
HEALTH CARE FOR TRANSGENDER PERSONS Tim Cavanaugh, MD Medical Director for the Trans Health Program Fenway Health 1 TRANSGENDER refers to a person who is born with the genetic traits of one gender but
More informationFertility Issues for Transgender Persons. Timothy Cavanaugh, MD Fenway Health
Fertility Issues for Transgender Persons Timothy Cavanaugh, MD Fenway Health Transgender refers to a person who is born with the genetic traits of one gender but has the internalized identity of another
More informationCross-Sex Hormone Therapy. Timothy Cavanaugh, MD Medical Director for Trans Health Team Fenway Health
Cross-Sex Hormone Therapy Timothy Cavanaugh, MD Medical Director for Trans Health Team Fenway Health Continuing Medical Education Disclosure Program Faculty: Tim Cavanaugh, MD Current Position: Medical
More informationCross-Sex Hormone Therapy. Timothy Cavanaugh, MD Medical Director for Trans Health Program Fenway Health
Cross-Sex Hormone Therapy Timothy Cavanaugh, MD Medical Director for Trans Health Program Fenway Health Continuing Medical Education Disclosure Program Faculty: Tim Cavanaugh, MD Current Position: Medical
More informationMeeting the Health Care Needs of Transgender People. Presenter: Julie Thompson, PA Fenway Health Boston, MA 18 November 2015
Meeting the Health Care Needs of Transgender People Presenter: Julie Thompson, PA Fenway Health Boston, MA 18 November 2015 Meeting the Health Care Needs of Transgender People Julie Thompson, PA Fenway
More informationTransgender Medicine beyond the guidelines.
Transgender Medicine beyond the guidelines. Rachel Hopkins, MD Assistant Professor of Medicine SUNY Upstate Medical University Division of Endocrinology and Metabolism Overview Definitions and history
More informationCross-Sex Hormone Therapy. Timothy Cavanaugh, MD Medical Director for Trans Health Program Fenway Health
Cross-Sex Hormone Therapy Timothy Cavanaugh, MD Medical Director for Trans Health Program Fenway Health Conflict of Interest Disclosure I have no financial relationships with a commercial entity producing
More informationTransgender Medicine in Primary Care. John-Paul Bettencourt, D.O., M.P.H., AAHIVS
Transgender Medicine in Primary Care John-Paul Bettencourt, D.O., M.P.H., AAHIVS jbettencourt@fenwayhealth.org Conflict of Interest Disclosure There are no conflicts of interest or financial relationships
More informationDisclosures. Endocrine Care of the Transgender Patient. Objectives. Start where you are. Use what you have. Do what you can. Vocabulary.
Disclosures Endocrine Care of the Transgender Patient Kathryn Tierney, MSN, APRN, FNP-BC Medical Director, Middlesex Hospital Transgender Medicine Program Middlesex Multispecialty Group Division of Endocrinology
More informationINFORMED CONSENT FOR FEMINIZING HORMONE THERAPY
INFORMED CONSENT FOR FEMINIZING HORMONE THERAPY The use of hormone therapy for gender transition/affirmation is based on many years of experience treating trans persons. Research on hormone therapy is
More informationHEALTH: Presented by: Alsean R. Bryant, Pharm.D., AAHIVP AIDS Healthcare Foundation
HEALTH: Presented by: Alsean R. Bryant, Pharm.D., AAHIVP AIDS Healthcare Foundation 1 The presenter has no actual or potential conflict of interest in relation to this presentation program. 2 Pharmacists:
More informationPatient education for transgender feminizing hormone therapy
Date name DOB Patient education for transgender feminizing hormone therapy o Some transsexual, transgender, and gender non-conforming people choose to take hormone therapy to treat gender dysphoria and
More informationPatient education for transgender masculinizing hormone therapy
Date name DOB Patient education for transgender masculinizing hormone therapy o Some transsexual, transgender, and gender non-conforming people choose to take hormone therapy to treat gender dysphoria
More informationProviding Primary Care for Gender-Diverse Clients. Seaway Valley Community Health Centre June 30 th, 2016 Jennifer Douek, Jordan Zaitzow
Providing Primary Care for Gender-Diverse Clients Seaway Valley Community Health Centre June 30 th, 2016 Jennifer Douek, Jordan Zaitzow Introductions Jennifer Douek, MD Jordan Zaitzow, MSW Faculty / Presenter
More informationAddressing Primary Care Preventive Needs of Transgender Patients. Julie Thompson, PA Fenway Health
Addressing Primary Care Preventive Needs of Transgender Patients Julie Thompson, PA Fenway Health 1 Continuing Medical Education Disclosure Program Faculty: Julie Thompson, PA Current Position: Physician
More informationEndocrinology and the Transgender Patient
Endocrinology and the Transgender Patient Matthew Leinung MD Professor of Medicine Albany Medical College This project is supported by the Health Resources and Services Administration (HRSA) of the U.S.
More informationPrimary Care and Preventive Health Needs of Transgender Patients. Julie Thompson, PA-C Fenway Health
Primary Care and Preventive Health Needs of Transgender Patients Julie Thompson, PA-C Fenway Health Continuing Medical Education Disclosure Program Faculty: Julie Thompson, PA-C Current Position: Physician
More informationCase Studies in Primary care
Case Studies in Primary care Holistic care of Transgender and Gender-nonconforming People Katy Kropf DO Ohio University Heritage College of Osteopathic medicine pronouns she/her/hers kropf@ohio.edu My
More informationQuestions of Definition
Gender & Sex Questions of Definition What is a person s sex versus a person s gender? [Do they, can they, differ?] Sociological versus biological definitions: Sex is more biological. male/female (i.e.,
More informationClinical Case Discussions
Clinical Case Discussions 9 th Floor: Sarah Eley, LICSW and Julie Thompson, PA-C 10 th Floor: Tim Cavanaugh, MD, Melissa Grieco-Waters, LICSW, and Lisa Moore, PhD, LICSW Continuing Medical Education Disclosure
More informationGENder Education and Care Interdisciplinary Support (GENECIS) Feminizing Medications for Patients with Gender Dysphoria
GENder Education and Care Interdisciplinary Support (GENECIS) Feminizing Medications for Patients with Gender Dysphoria Patient Information and Informed Consent and Assent for Minors Before using medications
More informationGender Health Center, Hormone Clinic th St #201 Sacramento, CA 95817
MTF Clinical Approach and Protocols Gender Health Center, Hormone Clinic Sacramento, CA Katherine Gardner, MD Revised 11/6/2015 Name and Pronouns: Preferred names and pronouns are used at all times when
More informationInformed Consent Form for Feminizing Medications
Student Health Services Oregon State University, 201 Plageman Building, Corvallis, Oregon 97331-8567 Tel 541-737-9355 General Fax 541-737-4530 Medical Fax 541-737-9665 http://studenthealth.oregonstate.edu/
More informationMODULE 1 F E M I N I Z I N G
MODULE 1 F E M I N I Z I N G MODULE 1 MEDICAL TRANSITION - FEMINIZING Objectives: Describe the basic science underpinning feminizing gender hormonal transition List the pharmacologic options including
More informationClient Information for Informed Consent FEMINIZING MEDICATIONS FOR TRANSGENDER CLIENTS
Client Information for Informed Consent FEMINIZING MEDICATIONS FOR TRANSGENDER CLIENTS Before using medications to transition and feminize, you need to know the possible advantages, disadvantages and risks
More informationInformation on Feminizing Medications
201 Plageman Building 108 SW Memorial Place Corvallis, Oregon 97331 P 541-737-9355 F 541-737-9694 studenthealth@oregonstate.edu Information on Feminizing Medications Persons in the male-to-female spectrum
More informationThere are four areas where you can expect changes to occur as your hormone therapy progresses. 1) Physical
You are considering taking feminizing hormones, so you should learn about some of the risks, expectations, long term considerations, and medications associated with medical transition. It is very important
More informationHypogonadism 4/27/2018. Male Hypogonadism -- Definition. Epidemiology. Objectives HYPOGONADISM. Men with Hypogonadism. 95% untreated.
Male Hypogonadism -- Definition - Low T, Low Testosterone Hypogonadism -...a clinical syndrome that results from failure of the testes to produce physiological concentrations of testosterone due to pathology
More informationTransgender Medicine: Essentials for the Primary Care Provider BENJAMIN J. BOH, DO, MS
Transgender Medicine: Essentials for the Primary Care Provider BENJAMIN J. BOH, DO, MS ASSISTANT PROFESSOR OF MEDICINE SECTION OF ENDOCRINOLOGY GEISEL SCHOOL OF MEDICINE AT DARTMOUTH Disclosure I will
More informationState of California, California Health and Human Services Agency, Department of Managed Health Care 2013:
This policy has been developed through review of medical literature, consideration of medical necessity, generally accepted medical practice standards, and approved by the IEHP Pharmacy and Therapeutics
More informationWhat to Know a 21 st Century Approach to Transgender Medical Care
What to Know a 21 st Century Approach to Transgender Medical Care Joshua Safer, MD Transgender Medicine Research Group Center for Transgender Medicine and Surgery Patient / Mental Health Provider Gatekeeper
More informationCLIENT INFORMATION and INFORMED CONSENT TESTOSTERONE THERAPY
CLIENT INFORMATION and INFORMED CONSENT TESTOSTERONE THERAPY This form explains the use of testosterone for someone who wishes to become more masculine as part of a gender transitioning process. Testosterone
More information10/07/18. Conflict of interest statement
Care: principles, best practices in Europe and how reproductive/sexual health care providers might contribute Petra De Sutter University Hospital Gent Conflict of interest statement My department occasionally
More informationEvaluation and Treatment of Primary Androgen Deficiency Syndrome in Male Patients
Evaluation and Treatment of Primary Androgen Deficiency Syndrome in Male Patients Jeff Unger, MD Director Chino Medical Group Diabetes and Headache Intervention Center Chino, California January 16, 2008
More informationPrimary Care for Transgender Pa5ents. Objec5ves. Transgender 2/22/17. Charleston APRN Conference February 2017
Primary Care for Transgender Pa5ents Charleston APRN Conference February 2017 Marty Player MD MS MUSC Department of Family Medicine Objec5ves Review terminology related to transgender people Review screening
More information8/17/2015. Objectives. Disclosures
NPANY Annual Conference Niagara Falls, NY October 2015 Laura Markwick, DNP, FNP C Associate Professor Wegmans School of Nursing St Joh Fisher College Objectives The learner will gain an understanding of
More informationCare for Transgender Patient: Providing Competent and Compassionate Care During a Time of Transition
Care for Transgender Patient: Providing Competent and Compassionate Care During a Time of Transition Jessica Francis, MD Assistant Professor Department of Obstetrics and Gynecology Froedtert and the Medical
More informationTrust Women Seattle Client Information for Informed Consent MASCULIZING MEDICATIONS FOR TRANSGENDER CLIENTS
Client Information for Informed Consent MASCULIZING MEDICATIONS FOR TRANSGENDER CLIENTS Before using medications to transition and Masculinize, you need to know the possible advantages, disadvantages and
More informationGender Confirming Healthcare Across the Lifespan. Dr. Tracey Wiese, APRN, FNP-BC, PMHNP-BC
Gender Confirming Healthcare Across the Lifespan Dr. Tracey Wiese, APRN, FNP-BC, PMHNP-BC What is gender confirming healthcare? Not just for trans clients Being aware of gender and sexuality concepts and
More informationTransgender Health Cases from the Transgender and Intersex Specialty Care Clinic
Transgender Health Cases from the Transgender and Intersex Specialty Care Clinic Caroline Davidge-Pitts, MD Todd B Nippoldt, MD Department of Endocrinology, Diabetes, Nutrition Mayo Clinic, Rochester 2017
More informationInformation on Testosterone Therapy
Information on Testosterone Therapy 201 Plageman Building 108 SW Memorial Place Corvallis, Oregon 97331 P 541-737-9355 F 541-737-9694 studenthealth@oregonstate.edu Persons in the female-to-male spectrum
More informationHarold Husovsky, MD. Associate Professor of General Medicine at SUNY Health Science Center
Harold Husovsky, MD Associate Professor of General Medicine at SUNY Health Science Center Care of the Transgendered Syracuse University, 1/09/07 Goals Introductions Definitions Statistics Evaluation Treatments
More informationGUIDELINES FOR THE USE OF FEMINISING HORMONE THERAPY IN GENDER DYSPHORIA. Information for Primary Care December 2015 (Review Date June 2016)
GUIDELINES FOR THE USE OF FEMINISING HORMONE THERAPY IN GENDER DYSPHORIA Information for Primary Care December 2015 (Review Date June 2016) Further information on this guideline can be obtained from: Claire
More informationReproductive Health and Obstetric Care in Transgender Patients. Rebekah P. Viloria, MD Obstetrician & Gynecologist Fenway Health
Reproductive Health and Obstetric Care in Transgender Patients Rebekah P. Viloria, MD Obstetrician & Gynecologist Fenway Health Continuing Medical Education Disclosure Program Faculty: Rebekah P. Viloria,
More informationInformation About Hormonal Treatment for Trans women
Information About Hormonal Treatment for Trans women Leighton J Seal PhD FRCP Consultant Endocrinologist, Gender Identity Clinic, (Charing Cross) West London Mental Health NHS Trust 12/12/2016 1 Introduction...
More informationTransgender Populations
Treating HIV in Transgender Patients: A Clinical Update Tonia Poteat, PhD, MPH, PA-C Physician Assistant, JHMI Assistant Professor, JHSPH 18 November 2016 Transgender Populations Transgender (trans): people
More informationThere are four areas where you can expect changes to occur as your hormone therapy progresses.
You are considering taking testosterone, so you should learn about some of the risks, expectations, long term considerations, and medications associated with medical transition. If is very important to
More informationDepartment of Pediatrics
Page 1 of 5 What is testosterone? Consent Form: MASCULINIZING MEDICATIONS You want to take testosterone to masculinize your body. Before taking it, there are several things you need to know about. They
More informationTRANSGENDER HEALTHCARE Barry Zevin, MD Conrad Wenzel, MSW
TRANSGENDER HEALTHCARE Barry Zevin, MD Conrad Wenzel, MSW Disclosures Dr. Zevin is an employee of the San Francisco Department of Public Health There are no other relevant financial or personal relationships
More informationDISCLOSURES LEARNING OBJECTIVES. 21st Century Strategies: Transgender Hormone Care. Patient/PCP. Medical model
21st Century Strategies: Transgender Hormone Care DISCLOSURES Joshua Safer, MD Center for Transgender Medicine and Surgery No conflicts of interest Just about the entire talk is "off label" LEARNING OBJECTIVES
More informationPharmacy Policy. Adult transgender hormonal therapy may be approved when all of the following criteria are met:
Pharmacy Policy Class: Transgender Hormonal Treatment for Adults Line of Business: Medi-Cal Effective date: February 15, 2017 Revision date: February 15, 2017 This policy has been developed through review
More informationIntegrating Transgender Health Care Into Our Medical Culture
Integrating Transgender Health Care Into Our Medical Culture JOHN F. RANDOLPH, JR., MD DIVISION OF REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY DEPARTMENT OF OBSTETRICS AND GYNECOLOGY UNIVERSITY OF MICHIGAN
More informationClinical Policy: Testosterone Pellet (Testopel) Reference Number: CP.CPA.## [Pre-P&T approval] Effective Date:
Clinical Policy: (Testopel) Reference Number: CP.CPA.## [Pre-P&T approval] Effective Date: 07.25.17 Last Review Date: 11.17 Line of Business: Commercial Coding Implications Revision Log See Important Reminder
More informationNorth of Tyne and Gateshead Area Prescribing Committee GUIDELINES FOR THE USE OF FEMINISING HORMONE THERAPY IN GENDER DYSPHORIA
North of Tyne and Gateshead Area Prescribing Committee GUIDELINES FOR THE USE OF FEMINISING HORMONE THERAPY IN GENDER DYSPHORIA Information for Primary Care July 2014 (Minor update November 2014) (Review
More informationAndrogens. Medication Strengths Quantity Limit Comments Androderm (testosterone patch) 1% pump 2 pump bottles per Non-Preferred
Market DC Androgens Override(s) Prior Authorization Quantity Limit Approval Duration Varies upon diagnosis Medication Strengths Quantity Limit Comments Androderm (testosterone patch) AndroGel (testosterone
More informationPrescribing Guidelines
Porterbrook Clinic Sheffield Gender Identity Clinic Michael Carlisle Centre 75 Osborne Road Sheffield S11 9BF Version V10 22-01-18 Tel: 0114 271 6671 Fax: 0114 271 8693 Email: Porterbrook@shsc.nhs.uk Website:
More informationA Guide to Feminizing Hormones Gender Affirming Care
Patient and Family Education A Guide to Feminizing Hormones Gender Affirming Care Hormone therapy is an option that can help transgender people feel more comfortable in their bodies. Like other medical
More informationPharmacy Coverage Guidelines are subject to change as new information becomes available.
TESTOSTERONE REPLACEMENT THERAPY: ANDRODERM transdermal patch ANDROGEL pump transdermal gel and transdermal gel AXIRON transdermal solution FORTESTA transdermal gel NATESTO nasal gel STRIANT buccal mucoadhesive
More informationGA KS KY LA MD NJ NV NY TN TX WA Applicable X X N/A N/A X N/A X X X X X X N/A N/A NA *FHK- Florida Healthy Kids. Androgens
Androgens Override(s) Prior Authorization Quantity Limit Approval Duration Varies upon diagnosis Medication Strengths Quantity Limit Comments Generic Androgel 1% (2.5 g) packet 2 packets per day (testosterone
More informationConsent for Testosterone Therapy-Men Revised 4/10/18
Consent for Testosterone Therapy in Men You have been diagnosed with or have an increased risk of having a hormone deficiency and your provider has recommended treatment with bio-identical hormone replacement
More informationPrimary and HIV Care for Our Transgender Patients
Primary and HIV Care for Our Transgender Patients James Hekman, MD FACP AAHIVS Clinical Assistant Professor Community Internal Medicine CWRU/Cleveland Clinic. Who are our TG patients? Demographics Those
More informationA Guide to Masculinizing Hormones Gender Affirming Care
Patient and Family Education A Guide to Masculinizing Hormones Gender Affirming Care Hormone therapy is an option that can help transgender people feel more comfortable in their bodies. Like other medical
More informationGuidelines for the Clinical Care of Persons with Gender Dysphoria
Guidelines for the Clinical Care of Persons with Gender Dysphoria Friday, May 27, 2016 2:15 5:00 PM 25 th Annual Scientific and Clinical Congress American Association of Clinical Endocrinologist Orlando,
More informationPrimary Care and Preventive Health Needs of Transgender Patients. Julie Thompson, PA-C Co-Medical Director for Transgender Health Fenway Health
Primary Care and Preventive Health Needs of Transgender Patients Julie Thompson, PA-C Co-Medical Director for Transgender Health Fenway Health Continuing Medical Education Disclosure Program Faculty: Julie
More informationCITY AND COUNTY OF SAN FRANCISCO
CITY AND COUNTY OF SAN FRANCISCO Department of Public Health Transgender Health Services 50 Lech Walesa Street San Francisco, CA 94102 Telephone: (415) 355-7498 FAX: (415) 355-7407 transgenderhealthservices@sfdph.org
More informationMale Hypogonadism. Types and causes of hypogonadism. What is male hypogonadism? Symptoms. Testosterone production. Patient Information.
Patient Information English 31 Male Hypogonadism The underlined terms are listed in the glossary. What is male hypogonadism? Male hypogonadism means the testicles do not produce enough of the male sex
More informationOestrogen, progestogens and assessing risks of hormones. Dr Naomi Achong BSc MBBS(Hons) FRACP Endocrinologist
Oestrogen, progestogens and assessing risks of hormones Dr Naomi Achong BSc MBBS(Hons) FRACP Endocrinologist My interest Minimal exposure during training Unmet need within endocrinology (private/public)
More informationInformation About Hormonal Treatment for Trans men
Information About Hormonal Treatment for Trans men Leighton J Seal PhD FRCP Consultant Endocrinologist, Gender Identity Clinic, (Charing Cross) West London Mental Health NHS Trust 12/12/2016 Introduction...
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Polycystic ovary syndrome (PCOS) is common. It can cause period problems, reduced fertility, excess hair growth, and acne. Many women with PCOS are also overweight. Treatment
More informationThe Transgender Patient and Medications
The Transgender Patient and Medications Deb Thorp, MD Medical Director Park Nicollet Gender Services Clinic Dr. Thorp indicated no potential conflict of interest to this presentation. She does intend to
More informationArti Barnes MD MPH Tuesday AM series ENCOMPASSING THE MARGINALIZED: CARE FOR THE TRANSGENDER COMMUNITY
Arti Barnes MD MPH Tuesday AM series 9-29-2015 ENCOMPASSING THE MARGINALIZED: CARE FOR THE TRANSGENDER COMMUNITY Disclosures None Objectives Increase awareness of HIV and STD epidemiology among Transgenders
More informationGuidelines for the Clinical Care of Persons with Gender Dysphoria
Guidelines for the Clinical Care of Persons with Gender Dysphoria Friday, May 27, 2016 2:15 5:00 PM 25 th Annual Scientific and Clinical Congress American Association of Clinical Endocrinologist Orlando,
More informationTHE SAFETY CHECK LIST BEFORE STARTING HT
THE SAFETY CHECK LIST BEFORE STARTING HT This safety checklist was designed by the Endocrine Society in 2015 to minimize the chance of giving hormone therapy to women who may be negatively affected by
More informationAndroderm patch, AndroGel packets and pump, Axiron solution, First- Testosterone, First-Testosterone MC, Fortesta gel, Testim gel, Vogelxo
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.31 Subject: Testosterone Topical Page: 1 of 9 Last Review Date: September 23, 2016 Testosterone topical
More informationTestosterone Therapy in Men with Hypogonadism
Testosterone Therapy in Men with Hypogonadism (Endocrine Society 2018 Guideline) Ngwe Yin, MD Assistant Clinical Professor of Medicine, UCSF Fresno Medical Education Program Disclosures None Objective
More informationPharmacy Coverage Guidelines are subject to change as new information becomes available.
TESTOSTERONE REPLACEMENT THERAPY: ANDRODERM transdermal patch ANDROGEL pump transdermal gel and transdermal gel ANDROID (methyltestosterone) oral capsule ANDROXY (fluoxymesterone) oral tablet AXIRON transdermal
More informationCurrent Topics in Hormone Replacement Therapy
Current Topics in Hormone Replacement Therapy Corey R. Babb, D.O., FACOOG, IF, NCMP Clinical Assistant Professor of Obstetrics and Gynecology Director of the Oklahoma State University Center for Women
More informationAppendix: Reference Table of HT Brand Names
Appendix: Reference Table of HT Brand Names This is a full reference table in alphabetical order, of Brand Name drugs used in HT. It is the basis for prescription advice throughout this handbook. Drug
More informationTransgender. Transgender Health and HIV. Transgender Terminology. Gender Identity & Sexual Orientation 12/8/17
Transgender Transgender Health and HIV Madeline B. Deutsch, MD, MPH Associate Professor of Clinical Family & Community Medicine Director, UCSF Transgender Care Center of Excellence for Transgender Health
More informationCaring for Trans and Gender Diverse Clients in BC: A Primary Care Toolkit
March 2017 Caring for Trans and Gender Diverse Clients in BC: A Primary Care Toolkit Version 1.0 Contents Table of Contents...i Acknowledgment and Disclaimer...ii Introduction... 1 Gender affirming health
More informationNational Gender Identity Clinical Network for Scotland (NGICNS)
National Gender Identity Clinical Network for Scotland (NGICNS) Endocrine Management of Adult Transgender Patients Revised 7 th July 2016 (First published 11 August 2015) This guidance is based on the
More informationWhat is PCOS? PCOS THE CONQUER PCOS E-BOOK. You'll be amazed when you read this...
PCOS What is PCOS? You'll be amazed when you read this... What is PCOS?. Who is at risk? How to get tested? What are the complications. Is there a cure? What are the right ways to eat? What lifestyle changes
More informationTransgender Treatment in High Risk Adolescents
Transgender Treatment in High Risk Adolescents Jeffrey M. Birnbaum 1,2, MD, MPH, Jennifer E. Lee, MPH 1, Jonovia Chase 1, Betsy Eastwood 3, PhD 1 Department of Pediatrics & Public Health/SUNY Downstate
More informationJamie Feldman M.D., Ph.D. Dept. of Family Medicine/Program in Human Sexuality University of Minnesota
Jamie Feldman M.D., Ph.D. Dept. of Family Medicine/Program in Human Sexuality University of Minnesota University of Illinois, Urbana-Champaign Urbana, IL February 9, 2016 } MSP from 1984-1993 PhD in Anthropology
More informationFeminising hormone treatment for trans women and non-binary people: Information for primary care professionals
1 Feminising hormone treatment for trans women and non-binary people: Information for primary care professionals Introduction The following information has been produced by the Nottingham Centre for Transgender
More information12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman
Polycystic Ovarian Syndrome (PCOS) for the Family Physician Barbara S. Apgar MD, MS Professor or Family Medicine University of Michigan Ann Arbor, Michigan Important references for PCOS Endocrine Society
More informationPharmacists' role in pharmacotherapy management of transgender patients
Pharmacists' role in pharmacotherapy management of transgender patients Ashley Floyd, Pharm.D. PGY1 Community Pharmacy Residency Program H-E-B Pharmacy The University of Texas at Austin 1 Objectives Recognize
More informationTestosterone (cypionate, enanthate, and propionate) powder, Fluoxymesterone powder, Methyltestosterone powder
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.37 Subject: Testosterone Powder Page: 1 of 12 Last Review Date: November 30, 2018 Testosterone powder
More informationApples & Oranges Synthetic vs. Bio-Identical Studied Under the Nation s Greats in Hormone Therapy! Salt Lake City Dr. Neal Rouzier Orlando Dr. Sangeeta Pati Naples Dr. Daved Rosensweet And finally Dallas
More informationIndex. urologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acquired hypogonadism, prevalence of, 165 167 primary, 165 secondary, 167 Adipose tissue, as an organ, 240 241 Adrenal hyperplasia, congenital,
More informationHRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College
HRT in Perimenopausal Women Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College 1 This is the Change But the CHANGE is not a disease 2 Introduction With a marked increase in longevity, women now
More informationClass Review: Cross sex Hormone Therapy
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationEndocrine Treatment of Gender-Dysphoric/ Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. Education Module June, 2017
Endocrine Treatment of Gender-Dysphoric/ Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline Education Module June, 2017 Introduction Wylie C. Hembree, MD Associate Attending Physician
More informationPolycystic ovary syndrome
Polycystic ovary syndrome Overview Polycystic ovary syndrome (PCOS) is a condition most often characterized by irregular menstrual periods, excess hair growth and obesity, but it can affect women in a
More information12/27/2013. Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND
Kristen Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo ND 7% of all women 18-45 Obesity 1/3 of all US women Incidence of PCOS is increasing with increase obesity Obesity Irregular
More informationGender Identity Services
Gender Identity Services www.sandyford.org 2 Contents Welcome to Sandyford....... 4 The Gender Identity Clinic...... 4 Treatment Options for Transsexual Women Male to Female (MTF)........ 6 Treatment Options
More informationMenopause. Medicines To Help You
Medicines To Help You Menopause Use this guide to help you talk to your doctor, pharmacist, or nurse about your hormone medicines. The guide lists all of the FDA-approved products now available to treat
More informationMetabolic Issues in Transgender Women Living With HIV. Jordan E. Lake, MD, MSc 2 November 2018
Metabolic Issues in Transgender Women Living With HIV Jordan E. Lake, MD, MSc 2 November 2018 Disclosures -No relevant financial disclosures Learning Objectives Understand metabolic issues relevant to
More information